10 listed pharmas like Samsung Pharm don’t even have an ability to pay interests with operating profits they make
10 listed pharmaceutical companies, such as Samsung Pharm, Binex and Aprogen Pharmaceuticals(formerly known as Schnell Biopharmaceuticals), reportedly have no ability to pay interests for their debts with sales they make.
On the contrary, 7 companies were analyzed a company rarely making debts.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
